Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry

Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical features

(2017) Jennifer M. Coughlin et al.   SCHIZOPHRENIA RESEARCH

Schizophrenia

(2016) Michael J Owen et al.   LANCET

Molecular substrates of schizophrenia: homeostatic signaling to connectivity

(2015) M A Landek-Salgado et al.   MOLECULAR PSYCHIATRY

Oxidative stress in bipolar and schizophrenia patients

(2015) Özgür Korhan Tunçel et al.   PSYCHIATRY RESEARCH

Brain disorders? Precisely

(2015) T. R. Insel et al.   SCIENCE

Oxidative stress and schizophrenia

(2014) Francesco E. Emiliani et al.   CURRENT OPINION IN PSYCHIATRY

Schizophrenia genetics: emerging themes for a complex disorder

(2014) D H Kavanagh et al.   MOLECULAR PSYCHIATRY

Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia

(2014) Jan-Harry Cabungcal et al.   NEURON

Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (BDNF) levels

(2014) A. R. Rosa et al.   PSYCHOLOGICAL MEDICINE

Inflammatory Molecular Signature Associated With Infectious Agents in Psychosis

(2014) Lindsay N. Hayes et al.   SCHIZOPHRENIA BULLETIN

Diffusion Tensor Imaging White Matter Endophenotypes in Patients With Schizophrenia or Psychotic Bipolar Disorder and Their Relatives

(2013) Pawel Skudlarski et al.   AMERICAN JOURNAL OF PSYCHIATRY

Gray Matter Volume as an Intermediate Phenotype for Psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP)

(2013) Elena I. Ivleva et al.   AMERICAN JOURNAL OF PSYCHIATRY

Is Aberrant Functional Connectivity A Psychosis Endophenotype? A Resting State Functional Magnetic Resonance Imaging Study

(2013) Sabin Khadka et al.   BIOLOGICAL PSYCHIATRY

Meta-Analysis of Oxidative Stress in Schizophrenia

(2013) Joshua Flatow et al.   BIOLOGICAL PSYCHIATRY

Confirmatory factor analysis reveals a latent cognitive structure common to bipolar disorder, schizophrenia, and normal controls

(2013) David J Schretlen et al.   BIPOLAR DISORDERS

Cognitive and motivational deficits together with prefrontal oxidative stress in a mouse model for neuropsychiatric illness

(2013) A. W. Johnson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophrenia

(2013) Martin Samuelsson et al.   PSYCHIATRY RESEARCH

No evidence of exogenous origin for the abnormal glutathione redox state in schizophrenia

(2013) Alejandro Ballesteros et al.   SCHIZOPHRENIA RESEARCH

Glutathione synthesis

(2012) Shelly C. Lu   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Early-Life Insults Impair Parvalbumin Interneurons via Oxidative Stress: Reversal by N-Acetylcysteine

(2012) Jan-Harry Cabungcal et al.   BIOLOGICAL PSYCHIATRY

Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia

(2012) J M Coughlin et al.   MOLECULAR PSYCHIATRY

Reduced antioxidant defense systems in schizophrenia and bipolar I disorder

(2012) Monia Raffa et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Antioxidants as potential therapeutics for neuropsychiatric disorders

(2012) Chirayu D. Pandya et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Glutathione is a physiologic reservoir of neuronal glutamate

(2011) Minori Koga et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

N-Acetylcysteine Normalizes Neurochemical Changes in the Glutathione-Deficient Schizophrenia Mouse Model During Development

(2011) Joao Miguel das Neves Duarte et al.   BIOLOGICAL PSYCHIATRY

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study

(2011) Juan Antonio Micó et al.   BMC Psychiatry

Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients

(2011) Monia Raffa et al.   BMC Psychiatry

Oxidative Stress in Schizophrenia

(2011) Iztok Grabnar et al.   Current Neuropharmacology

A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior

(2011) M Carlén et al.   MOLECULAR PSYCHIATRY

Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia

(2011) Susan B. Powell et al.   NEUROPHARMACOLOGY

Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia

(2011) David A. Lewis et al.   TRENDS IN NEUROSCIENCES

Endophenotypes: Bridging Genomic Complexity and Disorder Heterogeneity

(2009) Thomas R. Insel et al.   BIOLOGICAL PSYCHIATRY

Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study

(2009) Paul Lichtenstein et al.   LANCET

Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

(2009) Vikaas S. Sohal et al.   NATURE

Oxidative/Nitrative Modifications of Plasma Proteins and Thiols from Patients with Schizophrenia

(2009) Anna Dietrich-Muszalska et al.   NEUROPSYCHOBIOLOGY

Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients

(2009) Monia Raffa et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

(2008) Felicity Ng et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS Study

(2008) Daisuke Matsuzawa et al.   PLoS One

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia

(2008) Maurício Kunz et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY